Table 5.
Prescription of other medications in the past 12 months in the SABINA III Gulf cluster cohort
|
All (N = 301) |
Primary care physicians (n = 135) | Respiratory specialists (n = 162) | |||||
|---|---|---|---|---|---|---|---|
| Mild asthma (n = 32) |
Moderate-to-severe asthma (n = 103) |
All (n = 135) |
Mild asthma (n = 13) |
Moderate-to-severe asthma (n = 149) |
All (n = 162) |
||
| Prescription of ICS, n (%) | |||||||
| No | 274 (91) | 22 (68.8) | 99 (96.1) | 121 (89.6) | 7 (53.8) | 143 (96) | 150 (92.6) |
| Yes | 27 (9) | 10 (31.2) | 4 (3.9) | 14 (10.4) | 6 (46.2) | 6 (4) | 12 (7.4) |
| ICS canisters or inhalers prescribed in the past 12 months | |||||||
| Mean (SD) | 16.8 (20.9) | 26.7 (32.5) | 8.2 (7.5) | 21.4 (28.6) | 11.8 (2.9) | 11.7 (0.8) | 11.8 (2.0) |
| Median (min, max) | 12.0 (1.0, 110.0) | 12.0 (2.0, 110.0) | 7.5 (1.0, 17.0) | 12.0 (1.0, 110.0) | 12.0 (7.0, 16.0) | 12.0 (10.0, 12.0) | 12.0 (7.0, 16.0) |
| Total daily ICS dose, n (%) | |||||||
| Low dose | 12 (44.4) | 6 (60) | 2 (50) | 8 (57.1) | 2 (33.3) | 1 (16.7) | 3 (25) |
| Medium dose | 13 (48.1) | 3 (30) | 2 (50) | 5 (35.7) | 4 (66.7) | 4 (66.7) | 8 (66.7) |
| High dose | 2 (7.4) | 1 (10) | 0 (0) | 1 (7.1) | 0 (0) | 1 (16.7) | 1 (8.3) |
| Prescription of ICS/LABA fixed-dose combination, n (%) | |||||||
| No | 37 (12.3) | 24 (75) | 2 (1.9) | 26 (19.3) | 9 (69.2) | 0 (0) | 9 (5.6) |
| Yes | 264 (87.7) | 8 (25) | 101 (98.1) | 109 (80.7) | 4 (30.8) | 149 (100) | 153 (94.4) |
| Total daily ICS dose, n (%) | |||||||
| Low dose | 99 (37.8) | 6 (75) | 42 (41.6) | 48 (44) | 0 (0) | 51 (34.5) | 51 (33.6) |
| Medium dose | 114 (43.5) | 2 (25) | 48 (47.5) | 50 (45.9) | 4 (100) | 59 (39.9) | 63 (41.4) |
| High dose | 49 (18.7) | 0 (0) | 11 (10.9) | 11 (10.1) | 0 (0) | 38 (25.7) | 38 (25) |
| Missing values, n | 2 | 0 | 0 | 0 | 0 | 1 | 1 |
| Prescription of OCS burst treatment/short course, n (%) | |||||||
| No | 233 (77.4) | 28 (87.5) | 92 (89.3) | 120 (88.9) | 10 (76.9) | 99 (66.4) | 109 (67.3) |
| Yes | 68 (22.6) | 4 (12.5) | 11 (10.7) | 15 (11.1) | 3 (23.1) | 50 (33.6) | 53 (32.7) |
| Total daily dose, mg/day | |||||||
| Mean (SD) | 37.0 (30.4) | 38.3 (18.9) | 58.3 (71.7) | 54.0 (63.9) | 28.3 (12.6) | 32.8 (7.4) | 32.5 (7.6) |
| Median (min, max) | 30.0 (4.0, 200.0) | 30.0 (25.0, 60.0) | 27.0 (4.0, 200.0) | 28.5 (4.0, 200.0) | 30.0 (15.0, 40.0) | 30.0 (15.0, 40.0) | 30.0 (15.0, 40.0) |
| Number of days per prescription, n (%) | |||||||
| Mean (SD) | 5.1 (2.0) | 5.0 (0.0) | 5.1 (2.9) | 5.1 (2.5) | 4.7 (0.6) | 5.2 (1.9) | 5.1 (1.9) |
| Median (min, max) | 5.0 (1.0, 15.0) | 5.0 (5.0, 5.0) | 5.0 (1.0, 10.0) | 5.0 (1.0,10.0) | 5.0 (4.0, 5.0) | 5.0 (1.0, 15.0) | 5.0 (1.0, 15.0) |
| Prescription of antibiotics for asthma, n (%) | |||||||
| No | 229 (77.4) | 24 (80) | 84 (82.4) | 108 (81.8) | 12 (92.3) | 105 (71.4) | 117 (73.1) |
| Yes | 67 (22.6) | 6 (20) | 18 (17.6) | 24 (18.2) | 1 (7.7) | 42 (28.6) | 43 (26.9) |
| Missing values, n | 5 | 2 | 1 | 3 | 0 | 2 | 2 |
Prescriber type was not recorded for two patients each in mild asthma and moderate-to-severe asthma group
Abbreviations: ICS inhaled corticosteroids, LABA long-acting β2-agonist, max maximum, min minimum, OCS oral corticosteroids, SABINA SABA use IN Asthma, SD standard deviation